Targeted radiation tested for Tough-to-Treat cancer
NCT ID NCT06322576
Summary
This study aimed to test a targeted radiation treatment called 177Lu-PSMA for people with advanced adenoid cystic carcinoma, a rare salivary gland cancer that has spread or returned. The first part planned to see how the drug traveled in the body in 10 participants. If successful, a second part would have tested if the treatment could shrink tumors. The study was terminated early after enrolling only one person.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADENOID CYSTIC CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Johns Hopkins Hospital
Baltimore, Maryland, 21287, United States
Conditions
Explore the condition pages connected to this study.